EPISODE · Jul 1, 2017 · 8 MIN
Antibiotics: Skin infections and the FDA approval of Baxdela
from Outbreak News
The Food and Drug Administration recently approved a new antibiotic into the arsenal for treating serious acute bacterial skin and skin structure infections (ABSSSI). Its called delafloxacin and goes by the trade name, Baxdela and its manufactured by Melinta Therapeutics. Assistant Professor of Medicine, David Geffen School of Medicine at UCLA, James McKinnell, M.D. joined me to discuss the importance of this approval.
Embed this episode
NOW PLAYING
Antibiotics: Skin infections and the FDA approval of Baxdela
0:00
8:18
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Outbreak News?
This episode is 8 minutes long.
When was this Outbreak News episode published?
This episode was published on July 1, 2017.
Can I download this Outbreak News episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!